Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics of Cobitolimod Enemas in Participants with active left-sided Ulcerative Colitis

Next Previous
X
Search
Trial Profile

Pharmacokinetics of Cobitolimod Enemas in Participants with active left-sided Ulcerative Colitis

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Jun 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cobitolimod (Primary)
  • Indications Ulcerative colitis
  • Focus Pharmacokinetics; Registrational
  • Sponsors InDex Pharmaceuticals

    • Most Recent Events

    • 17 Oct 2023 Results (n=8) from a phase 1b portion of this trial presented at the 31st United European Gastroenterology Week
    • 22 Aug 2023 According to an InDex Pharmaceuticals media release, results from this trial will be presented on October 15 at 10:30 CET on Poster Stage 1, during the moderated poster session: Medical therapy of IBD: Facts and challenges and will also be presented at the United European Gastroenterology Week (UEGW) conference, 2023.
    • 22 Aug 2023 Results presented in the InDex Pharmaceuticals Media Release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top